Non-Hormonal Male Birth Control Pill YCT-529 Passes First Human Safety Trial

In Health & Wellness
February 24, 2026

A non-hormonal male birth control pill, YCT-529, has successfully cleared its first human safety trial, marking a significant milestone in the development of male contraceptives. The experimental pill offers hope for men seeking reliable, reversible, and hormone-free birth control options.

Developed by YourChoice Therapeutics in collaboration with Columbia University, YCT-529 works by blocking a vitamin A metabolite in the testes, a process essential for sperm production. By targeting this pathway, the pill temporarily halts sperm development without affecting testosterone levels, ensuring male hormonal balance remains intact.

The Phase 1a clinical trial involved 16 healthy male volunteers who received single doses of the drug. Researchers reported no serious adverse effects, no impact on testosterone or libido, and confirmed strong bioavailability, meaning the body efficiently absorbed the pill.

“The trial results are encouraging. YCT-529 shows promise as a safe and reversible contraceptive for men,” said one of the lead researchers.

The successful Phase 1a results pave the way for more advanced studies. Currently, a Phase 1b/2a trial is ongoing, testing repeat doses over 28-day and 90-day periods to further assess safety and efficacy. If these trials yield positive results, experts predict YCT-529 could become commercially available before the end of the decade.

Preclinical animal studies have already shown that YCT-529 is highly effective. In mice, the drug prevented pregnancies in 99% of cases, raising hopes that similar outcomes may be achievable in humans.

Health experts emphasize that the pill could be a game-changer in reproductive health, giving men more control over contraception while potentially easing the contraceptive burden traditionally borne by women.

“If approved, this could represent a major step toward balancing responsibility for family planning between partners,” said Dr. Elizabeth Irungu, a reproductive health specialist.

Unlike hormonal contraceptives, which can affect libido or cause other side effects, YCT-529’s non-hormonal mechanism makes it an attractive option for men concerned about maintaining natural hormone levels while preventing pregnancy.

As the drug progresses through clinical trials, researchers and advocates alike are optimistic that male contraception may soon expand beyond condoms and vasectomy, offering men a reliable, reversible, and safe method of birth control.